Annual FCF:
$172.34M+$27.01M(+18.58%)Summary
- As of today, AMPH annual free cash flow is $172.34 million, with the most recent change of +$27.01 million (+18.58%) on December 31, 2024.
- During the last 3 years, AMPH annual free cash flow has risen by +$101.81 million (+144.33%).
- AMPH annual free cash flow is now at all-time high.
Performance
AMPH Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly FCF:
$47.23M+$24.46M(+107.38%)Summary
- As of today, AMPH quarterly free cash flow is $47.23 million, with the most recent change of +$24.46 million (+107.38%) on September 30, 2025.
- Over the past year, AMPH quarterly free cash flow has increased by +$1.07 million (+2.31%).
- AMPH quarterly free cash flow is now -25.10% below its all-time high of $63.06 million, reached on June 30, 2024.
Performance
AMPH Quarterly Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
$111.00M+$1.07M(+0.97%)Summary
- As of today, AMPH TTM free cash flow is $111.00 million, with the most recent change of +$1.07 million (+0.97%) on September 30, 2025.
- Over the past year, AMPH TTM free cash flow has dropped by -$59.15 million (-34.76%).
- AMPH TTM free cash flow is now -37.68% below its all-time high of $178.13 million, reached on June 30, 2024.
Performance
AMPH TTM Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
AMPH Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +18.6% | +2.3% | -34.8% |
| 3Y3 Years | +144.3% | +227.2% | +24.2% |
| 5Y5 Years | +10000.0% | +1387.3% | +748.1% |
AMPH Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +164.6% | -25.1% | +430.0% | -37.7% | +117.6% |
| 5Y | 5-Year | at high | >+9999.0% | -25.1% | +1115.8% | -37.7% | +748.1% |
| All-Time | All-Time | at high | +740.8% | -25.1% | +328.4% | -37.7% | +579.7% |
AMPH Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $47.23M(+107.4%) | $111.00M(+1.0%) |
| Jun 2025 | - | $22.78M(-6.6%) | $109.94M(-26.8%) |
| Mar 2025 | - | $24.38M(+46.8%) | $150.23M(-12.8%) |
| Dec 2024 | $172.34M(+18.6%) | $16.61M(-64.0%) | $172.34M(+1.3%) |
| Sep 2024 | - | $46.17M(-26.8%) | $170.15M(-4.5%) |
| Jun 2024 | - | $63.06M(+35.6%) | $178.13M(+10.7%) |
| Mar 2024 | - | $46.50M(+222.4%) | $160.93M(+10.7%) |
| Dec 2023 | $145.34M(+123.1%) | $14.42M(-73.4%) | $145.34M(+3.9%) |
| Sep 2023 | - | $54.14M(+18.0%) | $139.83M(+39.7%) |
| Jun 2023 | - | $45.87M(+48.4%) | $100.12M(+96.2%) |
| Mar 2023 | - | $30.91M(+246.7%) | $51.02M(-21.2%) |
| Dec 2022 | $65.15M(-7.6%) | $8.91M(-38.3%) | $64.74M(-27.6%) |
| Sep 2022 | - | $14.44M(+546.1%) | $89.39M(+27.1%) |
| Jun 2022 | - | -$3.24M(-107.3%) | $70.30M(-29.7%) |
| Mar 2022 | - | $44.63M(+33.0%) | $99.96M(+41.7%) |
| Dec 2021 | $70.54M(+201.3%) | $33.56M(+821.8%) | $70.54M(+58.4%) |
| Sep 2021 | - | -$4.65M(-117.6%) | $44.54M(-14.9%) |
| Jun 2021 | - | $26.42M(+73.7%) | $52.37M(+16.0%) |
| Mar 2021 | - | $15.21M(+101.0%) | $45.15M(+92.8%) |
| Dec 2020 | $23.41M(>+9900.0%) | $7.56M(+138.2%) | $23.41M(+78.9%) |
| Sep 2020 | - | $3.18M(-83.5%) | $13.09M(+221.6%) |
| Jun 2020 | - | $19.20M(+394.1%) | -$10.77M(-189.5%) |
| Mar 2020 | - | -$6.53M(-136.7%) | $12.03M(>+9900.0%) |
| Dec 2019 | $207.00K | -$2.76M(+86.7%) | $56.00K(-98.0%) |
| Sep 2019 | - | -$20.68M(-149.2%) | $2.75M(-89.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2019 | - | $42.00M(+327.0%) | $26.58M(+214.8%) |
| Mar 2019 | - | -$18.50M(>-9900.0%) | -$23.14M(-168.6%) |
| Dec 2018 | -$8.62M(-309.7%) | -$65.00K(-102.1%) | -$8.62M(+3.2%) |
| Sep 2018 | - | $3.15M(+140.8%) | -$8.90M(+57.6%) |
| Jun 2018 | - | -$7.72M(-93.9%) | -$20.99M(-39.9%) |
| Mar 2018 | - | -$3.98M(-1027.5%) | -$15.00M(-465.0%) |
| Dec 2017 | $4.11M(-76.1%) | -$353.00K(+96.1%) | $4.11M(-68.7%) |
| Sep 2017 | - | -$8.94M(-417.7%) | $13.13M(-21.2%) |
| Jun 2017 | - | -$1.73M(-111.4%) | $16.67M(-25.3%) |
| Mar 2017 | - | $15.13M(+74.5%) | $22.32M(+30.0%) |
| Dec 2016 | $17.18M(+423.2%) | $8.67M(+260.4%) | $17.18M(+137.5%) |
| Sep 2016 | - | -$5.40M(-237.6%) | $7.23M(-47.2%) |
| Jun 2016 | - | $3.93M(-60.7%) | $13.71M(+64.7%) |
| Mar 2016 | - | $9.98M(+883.1%) | $8.32M(+255.1%) |
| Dec 2015 | -$5.32M(-1061.1%) | -$1.27M(-218.6%) | -$5.37M(-367.0%) |
| Sep 2015 | - | $1.07M(+173.7%) | -$1.15M(-114.2%) |
| Jun 2015 | - | -$1.46M(+60.6%) | $8.12M(+17.5%) |
| Mar 2015 | - | -$3.71M(-226.0%) | $6.91M(+1149.0%) |
| Dec 2014 | $553.00K(-95.7%) | $2.94M(-71.6%) | $553.00K(-77.1%) |
| Sep 2014 | - | $10.34M(+487.4%) | $2.42M(+130.6%) |
| Jun 2014 | - | -$2.67M(+73.5%) | -$7.92M(-50.8%) |
| Mar 2014 | - | -$10.06M(-309.2%) | -$5.25M(-4169.9%) |
| Dec 2013 | $12.74M(+147.4%) | $4.81M(+197.5%) | -$123.00K(+97.5%) |
| Mar 2013 | - | -$4.93M | -$4.93M |
| Dec 2012 | -$26.89M(-421.0%) | - | - |
| Dec 2011 | $8.38M | - | - |
FAQ
- What is Amphastar Pharmaceuticals, Inc. annual free cash flow?
- What is the all-time high annual free cash flow for Amphastar Pharmaceuticals, Inc.?
- What is Amphastar Pharmaceuticals, Inc. annual free cash flow year-on-year change?
- What is Amphastar Pharmaceuticals, Inc. quarterly free cash flow?
- What is the all-time high quarterly free cash flow for Amphastar Pharmaceuticals, Inc.?
- What is Amphastar Pharmaceuticals, Inc. quarterly free cash flow year-on-year change?
- What is Amphastar Pharmaceuticals, Inc. TTM free cash flow?
- What is the all-time high TTM free cash flow for Amphastar Pharmaceuticals, Inc.?
- What is Amphastar Pharmaceuticals, Inc. TTM free cash flow year-on-year change?
What is Amphastar Pharmaceuticals, Inc. annual free cash flow?
The current annual free cash flow of AMPH is $172.34M
What is the all-time high annual free cash flow for Amphastar Pharmaceuticals, Inc.?
Amphastar Pharmaceuticals, Inc. all-time high annual free cash flow is $172.34M
What is Amphastar Pharmaceuticals, Inc. annual free cash flow year-on-year change?
Over the past year, AMPH annual free cash flow has changed by +$27.01M (+18.58%)
What is Amphastar Pharmaceuticals, Inc. quarterly free cash flow?
The current quarterly free cash flow of AMPH is $47.23M
What is the all-time high quarterly free cash flow for Amphastar Pharmaceuticals, Inc.?
Amphastar Pharmaceuticals, Inc. all-time high quarterly free cash flow is $63.06M
What is Amphastar Pharmaceuticals, Inc. quarterly free cash flow year-on-year change?
Over the past year, AMPH quarterly free cash flow has changed by +$1.07M (+2.31%)
What is Amphastar Pharmaceuticals, Inc. TTM free cash flow?
The current TTM free cash flow of AMPH is $111.00M
What is the all-time high TTM free cash flow for Amphastar Pharmaceuticals, Inc.?
Amphastar Pharmaceuticals, Inc. all-time high TTM free cash flow is $178.13M
What is Amphastar Pharmaceuticals, Inc. TTM free cash flow year-on-year change?
Over the past year, AMPH TTM free cash flow has changed by -$59.15M (-34.76%)